Progyny (PGNY) Operating Expenses (2018 - 2026)

Progyny (PGNY) has 9 years of Operating Expenses data on file, last reported at $47.7 million in Q1 2026.

• Operating Expenses for Q1 2026 came in at $47.7 million, down 7.62% year-over-year; the trailing twelve-month figure through Mar 2026 was $215.3 million (up 11.17% YoY), and the FY2025 annual result was $219.2 million, up 17.91% from the prior year.
• Operating Expenses eased to $47.7 million in Q1 2026 per PGNY's latest filing, from $61.7 million in the prior quarter.
• Over five years, Operating Expenses peaked at $61.7 million in Q4 2025 and troughed at $33.0 million in Q1 2022.
• A 5-year average of $45.5 million and a median of $45.5 million in 2023 frame the typical range for Operating Expenses.
• The sharpest annual moves came in 2022 and 2026: Operating Expenses soared 95.1% in 2022, then declined 7.62% in 2026.
• A 5-year view of Operating Expenses shows it stood at $41.2 million in 2022, then gained by 4.63% to $43.1 million in 2023, then grew by 10.56% to $47.6 million in 2024, then gained by 29.41% to $61.7 million in 2025, then decreased by 22.65% to $47.7 million in 2026.
• Business Quant data shows PGNY's Operating Expenses at $47.7 million in Q1 2026, $61.7 million in Q4 2025, and $51.3 million in Q3 2025.